REACH2: ruxolitinib for refractory aGvHD
Crossref DOI link: https://doi.org/10.1038/s41571-020-0385-z
Published Online: 2020-05-06
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2020-05-06
Version of Record valid from 2020-05-06
Article History
First Online: 6 May 2020
Free to read: This content has been made available to all.